論文・技術情報追加のお知らせ

①A real-world disproportionality analysis of ospemifene: data mining of the public version of FDA adverse event reporting system.

オスペミフェンに関連する有害事象評価研究

対象DB：FAERS

②A real-world disproportionality analysis of Rucaparib: Post-marketing Pharmacovigilance Data.

ルカパリブに関連する有害事象評価研究

対象DB：FAERS

③Screening for clinically relevant drug-drug interactions between direct oral anticoagulants and antineoplastic agents: a pharmacovigilance approach.

直接経口抗凝固薬と抗悪性腫瘍薬間の薬物相互作用調査研究

対象DB：FAERS

④Drug-associated kidney injury in children: a disproportionality analysis of the FDA Adverse Event Reporting System.

小児における、腎障害リスクのある薬剤調査研究

対象DB：FAERS

⑤Angiotensin Receptor Blocker-Related Sprue-like Enteropathy: Review of Food and Drug Administration Adverse Event Reporting System.

オルメサルタンとスプルー様腸症との関連性調査研究

対象DB：FAERS

⑥Safety signals of albumin-bound paclitaxel: Data mining of the Food and Drug Administration adverse event reporting system.

アルブミン結合パクリタキセルの安全性評価研究

対象DB：FAERS

⑦Safety analysis of pemigatinib leveraging the US Food and Drug administration adverse event reporting system.

ペミガチニブの有害事象調査研究

対象DB：FAERS